Judith A Fox Selected Research

Judith A Fox Research Topics

11	Neoplasms (Cancer) 10/2022 - 05/2002
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2018 - 04/2010
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022 - 05/2009
2	Stomatitis 09/2015 - 02/2015
2	Multiple Myeloma 06/2010 - 09/2009
2	Ovarian Neoplasms (Ovarian Cancer) 04/2010 - 04/2010
1	Necrosis 05/2017
1	Glioblastoma (Glioblastoma Multiforme) 05/2017
1	Neutropenia 09/2015
1	Pneumonia (Pneumonitis) 09/2015
1	Sepsis (Septicemia) 09/2015
1	Febrile Neutropenia 09/2015
1	Cardiotoxicity 02/2015
1	Leukemia 10/2010
1	Headache (Headaches) 04/2008
1	Fatigue 04/2008
1	Melanoma (Melanoma, Malignant) 04/2008
1	Diarrhea 04/2008
1	Vomiting 04/2008
1	Nausea 04/2008
1	Hypertension (High Blood Pressure) 04/2008
1	Anorexia 04/2008
1	Reperfusion Injury 01/2002

8	vosaroxinIBA 11/2018 - 04/2010
6	QuinolonesIBA 05/2017 - 04/2010
5	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2018 - 10/2010
3	Agammaglobulinaemia Tyrosine KinaseIBA 10/2022 - 01/2022
3	vecabrutinibIBA 10/2022 - 01/2022
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 09/2016 - 04/2010
3	N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA 06/2010 - 05/2009
2	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 02/2015
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2009 - 05/2009
2	Proteins (Proteins, Gene)FDA Link 03/2006 - 05/2002
1	ibrutinibIBA 10/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 05/2017
1	AntigensIBA 12/2016
1	Gemtuzumab (Mylotarg)FDA Link 12/2016
1	IronIBA 02/2015
1	AnthracyclinesIBA 02/2015
1	PlatinumIBA 04/2010
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 04/2008
1	Alkaline PhosphataseIBA 04/2008
1	Pharmaceutical PreparationsIBA 04/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2008
1	tumor-associated antigen 72IBA 03/2006
1	ProdrugsIBA 03/2006
1	CarbohydratesIBA 03/2006
1	EpitopesIBA 03/2006
1	Death Domain ReceptorsIBA 05/2002
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2002
1	Topoisomerase I InhibitorsIBA 05/2002
1	LigandsIBA 05/2002
1	IntegrinsIBA 01/2002
1	adhesion receptorIBA 01/2002

1	Immunotherapy 12/2016
1	Therapeutics 04/2010